{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:00:16Z","timestamp":1783454416012,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,8,31]],"date-time":"2009-08-31T00:00:00Z","timestamp":1251676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Oxycodone is a semi\u2010synthetic opioid with a \u03bc\u2010receptor agonist\u2010mediated effect in several pain conditions, including post\u2010operative pain. Oxycodone is metabolized to its active metabolite oxymorphone by\n                    <jats:italic>O<\/jats:italic>\n                    \u2010demethylation via the polymorphic CYP2D6. The aim of this study was to investigate whether CYP2D6 poor metabolizers (PMs) yield the same analgesia post\u2010operatively from intravenous oxycodone as extensive metabolizers (EMs).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Two hundred and seventy patients undergoing primarily thyroid surgery or hysterectomy were included and followed for 24\u2003h post\u2010operatively. The\n                    <jats:italic>CYP2D6<\/jats:italic>\n                    genotype was blinded until study procedures had been completed for all patients. All patients received intravenous oxycodone as pain treatment for 24\u2003h post\u2010operatively and morphine 5\u2003mg was used as escape medication. A responder was characterized as a patient without the need for escape medication and a positive evaluation in a questionnaire 24\u2003h post\u2010operatively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Twenty\u2010four patients were PM (8.9%) and 246 were EM (91.1%). One PM (4.17%, CI=0.1\u201321.1) was a non\u2010responder and 42 EM (17.07%, CI=12.6\u201322.4) were non\u2010responders. The non\u2010responder rate did not differ between the two genotypes (\n                    <jats:italic>P<\/jats:italic>\n                    =0.14). There was no difference in the total consumption of oxycodone between the two genotypes (EM=14.7\u2003mg, CI=13.0\u201316.4 and PM=13.0\u2003mg, CI=8.9\u201317.0,\n                    <jats:italic>P<\/jats:italic>\n                    =0.42). The mean oxymorphone\/oxycodone ratios were 0.0031 and 0.00081 in the EMs and PMs, respectively (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0001).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    This study showed for the first time in patients that the oxymorphone formation depends on CYP2D6, but we found no difference in the post\u2010operative analgesic effect of intravenous oxycodone between the two\n                    <jats:italic>CYP2D6<\/jats:italic>\n                    genotypes.\n                  <\/jats:p>","DOI":"10.1111\/j.1399-6576.2009.02104.x","type":"journal-article","created":{"date-parts":[[2009,8,31]],"date-time":"2009-08-31T05:30:38Z","timestamp":1251696638000},"page":"232-240","source":"Crossref","is-referenced-by-count":93,"title":["Impact of the\n                    <i>CYP2D6<\/i>\n                    genotype on post\u2010operative intravenous oxycodone analgesia"],"prefix":"10.1111","volume":"54","author":[{"given":"S. T.","family":"ZWISLER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.","family":"ENGGAARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"MIKKELSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"BROSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"SINDRUP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,8]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"451","article-title":"Oxycodone. Pharmacological profile and clinical data in chronic pain management","volume":"71","author":"Coluzzi F","year":"2005","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1998.tb05169.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-199912000-00004"},{"key":"e_1_2_7_5_2","first-page":"461","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects","volume":"79","author":"Lalovic B","year":"2006","journal-title":"role of circulating active metabolites"},{"key":"e_1_2_7_6_2","first-page":"801","article-title":"Antinociception by spinal and systemic oxycodone","volume":"105","author":"Lemberg KK","year":"2006","journal-title":"why does the route make a difference? In vitro and in vivo studies in rats"},{"key":"e_1_2_7_7_2","first-page":"9","article-title":"Polymorphic metabolism of opioid narcotic drugs","volume":"20","author":"Mikus G","year":"1991","journal-title":"possible clinical implications"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00093-6"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.4.447"},{"key":"e_1_2_7_10_2","unstructured":"RasmussenI.Identification of cytochrome P450 isoforms involved in the metabolism of oxycodone.2000;1\u2013139."},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)31396-0","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone","volume":"207","author":"Beaver WT","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181605a15"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200104000-00007"},{"key":"e_1_2_7_14_2","first-page":"1624","article-title":"In vivo blood\u2010brain barrier transport of oxycodone in the rat","volume":"34","author":"Bostrom E","year":"2006","journal-title":"indications for active influx and implications for pharmacokinetics\/pharmacodynamics"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318164cf9e"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90051-0"},{"key":"e_1_2_7_17_2","first-page":"225","article-title":"CYP2D6 phenotype prediction from genotype","volume":"83","author":"Kirchheiner J.","year":"2008","journal-title":"which system is the best?"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100095"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00316090"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00195938"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_2_7_22_2","first-page":"458","article-title":"Tramadol as a new probe for cytochrome P450 2D6 phenotyping","volume":"77","author":"Pedersen RS","year":"2005","journal-title":"a population study"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00378.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-002-0427-1"},{"key":"e_1_2_7_25_2","first-page":"1000","article-title":"Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery","volume":"29","author":"Aqua K","year":"2007","journal-title":"a randomized, double-blind, active- and placebo-controlled, parallel-group trial"},{"key":"e_1_2_7_26_2","first-page":"496","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies","volume":"116","author":"Ingelman\u2010Sundberg M","year":"2007","journal-title":"pharmacogenetic, pharmacoepigenetic and clinical aspects"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000239974.69464.f2"},{"key":"e_1_2_7_28_2","first-page":"23","article-title":"Cytochrome P450 2D6","volume":"369","author":"Zanger UM","year":"2004","journal-title":"overview and update on pharmacology, genetics, biochemistry"},{"issue":"2","key":"e_1_2_7_29_2","first-page":"17","article-title":"Pharmacogenetics of cytochrome p4502D6","volume":"33","author":"Cascorbi I.","year":"2003","journal-title":"genetic background and clinical implication"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90211-8"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00212-4"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(96)00050-4"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.2009.02104.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.2009.02104.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:40:26Z","timestamp":1739295626000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.2009.02104.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1399-6576.2009.02104.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.2009.02104.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9159964.9747063","asserted-by":"object"}]},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,8]]}}}